Tag: Big Pharma

The integration of human genetics in pharmaceutical research significantly enhances drug development. By prioritizing targets with genetic support, companies can improve trial efficacy and reduce risks. Utilizing genomics allows for better indication selection, safety predictions, and asset valuation. This strategic approach fosters innovation while addressing ethical considerations in clinical trials.